MIRA
INFORM REPORT
|
Report Date : |
04.01.2008 |
IDENTIFICATION
DETAILS
|
Name : |
GITTOCS
PHARMACEUTICALS PVT. LTD |
|
|
|
|
Registered Office : |
Po Box 3899, Kampala |
|
|
|
|
Country : |
Uganda |
|
|
|
|
Date of Incorporation : |
16.05.2004 |
|
|
|
|
Legal Form : |
Limited
Liability company, Limited by shares |
|
|
|
|
Line of Business : |
Importers &
Distributors of Drugs and Related pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Maximum Credit Limit : |
USD 60,000 |
|
|
|
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
COMPANY REPORTED
GITTOCS
PHARMACEUTICALS PVT. LTD
Actual Name
GITTOES
PHARMACEUTICALS PVT. LTD
Principal Address
Po Box 3899, Kampala, Uganda
Telephone: +256-41237516
Fax:+256-41-349403 / 04
Email
kogollah@alembic.co.in
Internet
None
Established
16/5/2004
Registration
Kampala, Uganda
Legal Form
Limited Liability
company, Limited by shares
Stock Listing
Not Listed
Workforce
2006
20
Office & Factories
Head offices Plot No. 11, William Street, Kampala, Uganda
Branches None
Company Profile
Paid in Capital UGX. 100,000,000
Subscribed Capital
UGX. 100,000,000
Shareholders
Name Position Amount
Ratio
Mr. Ken Ogollah Director 50.00%
Mrs. Pam Ogollah Director 50.00%
Total 100.00%
Credit Opinion
Our proposed credit amount of USD 60,000 is recommendable
Affiliated Companies
None
Management/ Directors
President/ CEO (1)
Name Mr.
Ken Ogollah
Remarks Top
Decision Maker
Þ Top decision maker is the person who has the
ultimate authority or power to make important managerial decisions. He/She may
or may not be officially registered as a president or an executive director.
Business Activities
Importers &
Distributors of Drugs and Related pharmaceutical Products
Terms of payment
Buying terms 30% in cash, 70% on credit
Selling terms 80% in cash, 20% on credit
Suppliers
Aurobindo Pharma, Darbur
Customers
Hospitals, healthcare and
Other companies
Recent Sales
UGX. 1,250,000,000
(2006)
Exports
None
Export Ratio
0.0%
Import Ratio
80.0%
Domestic Market Share
30.0%
Banking relationship
Main Banks Stanbic Bank
Credit Check of Subject,
President & CEO (as of report date)
Payment Morale:
In the documents at our disposal nothing
adverse has been shown so far.
CREDIT RATING:
Financial situation is average.
COMMENTS
Maximum credit we recommend is USD 60,000 outstanding at any one time.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to
assess SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial condition (40%) Ownership background (20%) Payment
record (10%)
Credit history (10%) Market trend (10%) Operational
size (10%)